Protracted Results of Dose-Intensive Therapy using Cyclophosphamide, Carmustine, and Continuous Infusion Etoposide with Autologous Stem Cell Support in Patients with Relapse or Refractory Hodgkin's Disease: A Phase II Study from the North American Marrow Transplant Group

Donald R. Fleming University of Louisville, School of Medicine, James Graham Brown Cancer Center, Division of Hematology/Oncology, 529 South Jackson Street, Room 230, Louisville, KY, 40202; Department of Biostatistics, Health Sciences Center, 500 South Preston Street, Room 230, Louisville, KY, 40202

Steven N. Wolf Vanderbrlt Universrty Medical Center, Bone Marrow Transplantation Program 808 Oxford House, Vanderbilr University, Nashville, TN, 37232; Department of Biostatistics, Health Sciences Center, 500 South Preston Street, Room 230, Louisville, KY, 40202

Joseph W. Fay Baylor University Medical Center, Charles A. Sammons Cancer Center, Blood and Marrow Transplantation Services, 3535 Worth Street, Dallas, TX, 75246; Department of Biostatistics, Health Sciences Center, 500 South Preston Street, Room 230, Louisville, KY, 40202

Randy A. Brown Washington University School of Medicine, Division of Bone Marrow Transplantation and Stem Cell Biology, 660 South Euclid, Box 8007, Saint Louis, MO, 63110; Department of Biostatistics, Health Sciences Center, 500 South Preston Street, Room 230, Louisville, KY, 40202

Joseph P. Lynch West Virginia University Medical Center, Mary Babb Randolph Cancer Center, Bone Marrow Transplanration Program, Section of Hematology/Oncology, I Medical Center Drive, Morgantown, WV, 26506; Department of Biostatistics, Health Sciences Center, 500 South Preston Street, Room 230, Louisville, KY, 40202

Brian J. Bolwell Cleveland Clinic Foundrrtion, 9500 Euclid Avenue, Cleveland, OH, 44106, USA; Department of Biostatistics, Health Sciences Center, 500 South Preston Street, Room 230, Louisville, KY, 40202

Don A. Stevens University of Louisville, School of Medicine, James Graham Brown Cancer Center, Division of Hematology/Oncology, 529 South Jackson Street, Room 230, Louisville, KY, 40202; Department of Biostatistics, Health Sciences Center, 500 South Preston Street, Room 230, Louisville, KY, 40202

Stacy A. Goodman Vanderbrlt Universrty Medical Center, Bone Marrow Transplantation Program 808 Oxford House, Vanderbilr University, Nashville, TN, 37232; Department of Biostatistics, Health Sciences Center, 500 South Preston Street, Room 230, Louisville, KY, 40202

John P. Greer Vanderbrlt Universrty Medical Center, Bone Marrow Transplantation Program 808 Oxford House, Vanderbilr University, Nashville, TN, 37232; Department of Biostatistics, Health Sciences Center, 500 South Preston Street, Room 230, Louisville, KY, 40202

Richard S. Stein Vanderbrlt Universrty Medical Center, Bone Marrow Transplantation Program 808 Oxford House, Vanderbilr University, Nashville, TN, 37232; Department of Biostatistics, Health Sciences Center, 500 South Preston Street, Room 230, Louisville, KY, 40202

Luis A. Pineiro Baylor University Medical Center, Charles A. Sammons Cancer Center, Blood and Marrow Transplantation Services, 3535 Worth Street, Dallas, TX, 75246; Department of Biostatistics, Health Sciences Center, 500 South Preston Street, Room 230, Louisville, KY, 40202

Robert H. Collins Baylor University Medical Center, Charles A. Sammons Cancer Center, Blood and Marrow Transplantation Services, 3535 Worth Street, Dallas, TX, 75246; Department of Biostatistics, Health Sciences Center, 500 South Preston Street, Room 230, Louisville, KY, 40202

Linda Jane Goldsmith University of Louisville, School of Medicine, James Graham Brown Cancer Center, Division of Hematology/Oncology, 529 South Jackson Street, Room 230, Louisville, KY, 40202; Department of Biostatistics, Health Sciences Center, 500 South Preston Street, Room 230, Louisville, KY, 40202

Geoffrey P. Herzig Washington University School of Medicine, Division of Bone Marrow Transplantation and Stem Cell Biology, 660 South Euclid, Box 8007, Saint Louis, MO, 63110; Department of Biostatistics, Health Sciences Center, 500 South Preston Street, Room 230, Louisville, KY, 40202

Roger H. Herzig University of Louisville, School of Medicine, James Graham Brown Cancer Center, Division of Hematology/Oncology, 529 South Jackson Street, Room 230, Louisville, KY, 40202; Department of Biostatistics, Health Sciences Center, 500 South Preston Street, Room 230, Louisville, KY, 40202

show all

Protracted Results of Dose-Intensive Therapy using Cyclophosphamide, Carmustine, and Continuous Infusion Etoposide with Autologous Stem Cell Support in Patients with Relapse or Refractory Hodgkin's Disease: A Phase II Study from the North American Marrow Transplant Group

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Protracted Results of Dose-Intensive Therapy using Cyclophosphamide, Carmustine, and Continuous Infusion Etoposide with Autologous Stem Cell Support in Patients with Relapse or Refractory Hodgkin's Disease: A Phase II Study from the North American Marrow Transplant Group

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date